144 related articles for article (PubMed ID: 7407970)
1. [Results of immunochemotherapy in malignant melanoma].
Duchková H; Richter J; Kubíková M; Peska J; Ragan J; Vohryzková E; Hrivnáková J; Kvasnicka J
Cesk Dermatol; 1980 Aug; 55(4):277-80. PubMed ID: 7407970
[No Abstract] [Full Text] [Related]
2. Immunotherapy of malignant melanoma.
Thiers BH
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):559-62. PubMed ID: 6176602
[No Abstract] [Full Text] [Related]
3. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
[TBL] [Abstract][Full Text] [Related]
4. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
5. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
Pullmann H; Muth M
Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
[No Abstract] [Full Text] [Related]
6. Letter: Chemoimmunotherapy of malignant melanoma.
N Engl J Med; 1975 Jan; 292(3):159-60. PubMed ID: 1196343
[No Abstract] [Full Text] [Related]
7. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
Korting HC; Strasser S; Konz B
Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
[TBL] [Abstract][Full Text] [Related]
8. Changes in the rosette forming capacity of lymphocytes after surgery or surgery and immunochemotherapy of malignant melanoma in man.
Hadjikirova M; Boeva M; Ikonopisov R
Biomed Pharmacother; 1982; 36(5):257-9. PubMed ID: 7168802
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in the management of malignant melanoma.
Lichtenfeld JL
Am J Med Sci; 1976; 272(2):185-95. PubMed ID: 1008080
[No Abstract] [Full Text] [Related]
10. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
Zaumseil RP; Wohlrab W; Fiedler H; Wozniak KD
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):721-4. PubMed ID: 6172340
[No Abstract] [Full Text] [Related]
11. [Immunological aspects in the treatment of malignant melanoma].
Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
[No Abstract] [Full Text] [Related]
12. [5-year results of a chemo-immunotherapeutic treatment in stage-I and -II malignant melanoma].
Comella G; Mastro AA; Comella P; Castello G; De Simone G; Cerra R; Zarrilli D
Minerva Med; 1986 Mar; 77(13):507-10. PubMed ID: 3703343
[No Abstract] [Full Text] [Related]
13. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
Dandapat MC; Mohapatra SK; Patra SK
Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124
[No Abstract] [Full Text] [Related]
14. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
[TBL] [Abstract][Full Text] [Related]
15. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
16. [Immunostimulation in the treatment of rheumatoid arthritis (author's transl)].
Rosenthal M
Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1431-4. PubMed ID: 928307
[No Abstract] [Full Text] [Related]
17. Malignant melanoma.
Spitler LE
J Invest Dermatol; 1976 Sep; 67(3):435-41. PubMed ID: 787436
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma (stage IIIB): a pilot study of adjuvant chemo-immunotherapy.
Paterson AH; McPherson TA; Willans DJ
Cancer Treat Rep; 1978 Apr; 62(4):571-3. PubMed ID: 350395
[No Abstract] [Full Text] [Related]
19. Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.
Kaufman SD; Cosimi AB; Wood WC; Carey RW
Recent Results Cancer Res; 1978; 68():380-6. PubMed ID: 752874
[No Abstract] [Full Text] [Related]
20. Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival.
Gutterman JU; Richman SP; McBride CM; Burgess MA; Bartold SL; Kennedy A; Gehan EA; Mavligit G; Hersh EM
Recent Results Cancer Res; 1978; 68():359-62. PubMed ID: 752870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
